Discovery of antibody structure could lead to treatment for Crimean Congo Hemorrhagic Fever virus:…
A research team led by the University of California, Riverside, has discovered important details about how therapeutically relevant human monoclonal antibodies can protect against Crimean Congo Hemorrhagic Fever virus, or CCHFV. Their work,…